F5. CIRCULATING IGFBP-2 LEVELS REVEAL ATHEROGENIC METABOLIC RISK IN SCHIZOPHRENIC PATIENTS USING ATYPICAL ANTIPSYCHOTICS
Sign Up to like & getrecommendations! Published in 2019 at "Schizophrenia Bulletin"
DOI: 10.1093/schbul/sbz018.417
Abstract: Objectives: Second generation antipsychotics (SGAs) induce weight gain and dyslipidemia, albeit with important intervariability. Insulin-like growth factor binding protein (IGFBP)-2 is proposed as a circulating biomarker negatively associated with waist circumference and hypertriglyceridemia. Thus, we… read more here.
Keywords: igfbp levels; metabolic risk; risk schizophrenic; patients using ... See more keywords
Evaluation of serum FoxO1, mTORC1, IGF‐1, IGFBP‐3 levels, and metabolic syndrome components in patients with acne vulgaris: A prospective case‐control study
Sign Up to like & getrecommendations! Published in 2020 at "Dermatologic Therapy"
DOI: 10.1111/dth.13887
Abstract: Recently, insulin‐like growth factor‐1 (IGF‐1), forkhead box transcription factor (Fox) O1, and mechanistic target of rapamycin complex 1 (mTORC1) signaling have been introduced as key elements in acne pathogenesis. The aim of this study is… read more here.
Keywords: mtorc1; igfbp levels; foxo1 mtorc1; patients controls ... See more keywords
Effects of high-dose recombinant human growth hormone treatment on IGF-1 and IGFBP-3 levels in idiopathic dwarfism patients
Sign Up to like & getrecommendations! Published in 2022 at "Pakistan Journal of Medical Sciences"
DOI: 10.12669/pjms.38.4.5502
Abstract: Objective: To investigate the effects of high-dose recombinant human growth hormone(rhGH) treatment on insulin-like growth factor-1 (IGF-1) and insulin-like growth factor binding protein-3 (IGFBP-3) levels in patients with idiopathic dwarfism. Methods: This study retrospectively investigated… read more here.
Keywords: igfbp levels; growth; high dose; treatment ... See more keywords
IGFBP-2 and aging: a 20-year longitudinal study on IGFBP-2, IGF-I, BMI, insulin sensitivity and mortality in an aging population.
Sign Up to like & getrecommendations! Published in 2019 at "European journal of endocrinology"
DOI: 10.1530/eje-18-0422
Abstract: Objective Insulin-like growth factor-binding protein-2 (IGFBP-2) concentrations are low in subjects with metabolic syndrome and type 2 diabetes. Intriguingly, recent studies have demonstrated an association between high IGFBP-2 concentrations and increased mortality not only in… read more here.
Keywords: igfbp levels; insulin sensitivity; insulin; igfbp ... See more keywords
The impact of circulating IGF-1 and IGFBP-2 on cardiovascular prognosis in patients with acute coronary syndrome
Sign Up to like & getrecommendations! Published in 2023 at "Frontiers in Cardiovascular Medicine"
DOI: 10.3389/fcvm.2023.1126093
Abstract: Background While insulin-like growth factor 1 (IGF-1) exerts a cardioprotective effect in the setting of atherosclerosis, insulin-like growth factor binding protein 2 (IGFBP-2) is involved in metabolic syndrome. Although IGF-1 and IGFBP-2 are known to… read more here.
Keywords: igf igfbp; coronary syndrome; igfbp levels; acute coronary ... See more keywords
Evaluation of circulating IGF-I and IGFBP-3 as biomarkers for tumors in dogs.
Sign Up to like & getrecommendations! Published in 2021 at "Journal of veterinary science"
DOI: 10.4142/jvs.2021.22.e77
Abstract: BACKGROUND Serum-based parameters are considered non-invasive biomarkers for cancer detection. In human studies, insulin-like growth factor-I and II (IGF-I and IGF-II) and insulin-like growth factor binding protein-3 (IGFBP-3) are useful as diagnostic or prognostic markers… read more here.
Keywords: igfbp; dogs tumors; igfbp levels; healthy dogs ... See more keywords